PATENT CLAIM ANALYSIS

Application Number: 16183050
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["424", "197110"]

Abstract:
The invention provides a conjugate of a  Neisseria meningitidis  serogroup X capsular polysaccharide and a carrier molecule. The conjugate is typically made by (a) oxidising a primary hydroxyl group in the capsular polysaccharide, to give an oxidised polysaccharide with an aldehyde group; and (b) coupling the oxidised polysaccharide to a carrier molecule via the aldehyde group, thereby giving the conjugate. The conjugate may be part of an immunogenic composition. This composition may comprise one or more further antigens, particularly capsular polysaccharides from serogroups A, W135, C and Y and conjugated forms thereof. The composition may be in an aqueous formulation. The composition is useful as a vaccine, e.g. for raising an immune response in a mammal. The invention also provides processes for making the conjugate.

Claim (Index 31):
The composition of  claim 29 , wherein the carrier protein comprises a fusion protein comprising an spr0096 antigen polypeptide sequence and an spr2021 antigen polypeptide sequence.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.84615
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14401024', '12321417', '12353409', '12321418', '12321434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7485577908483063
- 35 USC 102 Novelty (BERT): 0.6018710458484354
- Combined Prediction Score: 0.7338891163483192
- Mean Citation Score: 494.26098200000007
- Max Citation Score: 768.3376
- Similarity Product: 430.61761491508486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test